Disposition of antimony and aminosidine combination after multiple subcutaneous injections in dogs

Veterinary Journal

Volumn 157, Issue 3, 1999, Pages 315-321

  Belloli, C ^a   Crescenzo, G ^b   Carli, S ^a   Zaghini, A ^c   Mengozzi, G ^d   Bertini, S ^d   Ormas, P ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Aminosidine; Antimony; Disposition; Dog; Leishmaniasis

Indexed keywords

AMINOFARMA; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIPROTOZOAL AGENT; MEGLUMINE ANTIMONATE; PAROMOMYCIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; FEMALE; FLUOROMETRY; ION PAIR CHROMATOGRAPHY; KIDNEY FUNCTION; MALE; NONHUMAN; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0032946587     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1053/tvjl.1998.0301     Document Type: Article

References (32)

1. BELLOLI, C., CECI, L., CARLI, S., TASSI, P., MONTESISSA, C., DE NATALE, G., MARCOTRIGIANO, G. & ORMAS, P. (1995). Disposition of antimony and aminosidine in dogs after administration separately and together: implications for therapy of leishmaniasis. Research in Veterinary Science 58, 123-7.
2. BELLOLI, C., CRESCENZO, G., CARLI, S., VILLA, R., SONZOGNI, O., CARELLI, G. & ORMAS, P. (1996). Pharmacokinetics and dosing regimen of aminosidine in the dog. Veterinary Research Communications 20, 533-41.
3. BROWN, S.A. & RIVIERE, J.E. (1991). Comparative pharmacokinetics of aminoglycoside antibiotics. Journal of Veterinary Pharmacology and Therapeutics 14, 1-35.
4. CHULAY, J.D., FLECKENSTEIN, L. & SMITH, D.H. (1988). Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 69-72.
5. CHUNGE, C.N., OWATE, J., PAMBA, H.O. & DONNO, L. (1990). Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Transactions of the Royal Society of Tropical Medicine and Hygiene 84, 221-5.
6. CROFT, S.L. (1988). Recent developments in the chemotherapy of leishmaniasis. Trends in Pharmacological Sciences 9, 376-81.
7. DAVIDSON, R.N. & CROFT, S.L. (1993). Recent advances in the treatment of visceral leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 87, 130-1.
8. DE NATALE, G., FIORENTINO, A., STORELLI, M.M. & BUSCO, V.P. (1990). Metodo rapido per la determinazione del glucantim nel siero e nell'urina median te spettrofluorimetria. Atti Società Italiana Scienze Veterinarie 44, 1127-31.
9. GEBRE-HIWOT, A., TADESSE, G., CROFT, S.L. & FROMMEL, D. (1992). An in vitro model for screening antileishmanial drugs: the human leukaemia monocyte cell line, THP-1. Acta Tropica 51, 237-45.
10. GIBALDI, M. & PERRIER, D. (1982a). Method of residuals. In Pharmacokinetics. Drugs and the Pharmaceutical Sciences, vol. 15, ed. J. Swarbrick, pp. 433-44. New York and Basel: Marcel Dekker.
11. GIBALDI, M. & PERRIER, D. (1982b). Prediction of drug concentration on multiple dosing using the principle of superimposition. In Pharmacokinetics. Drugs and the Pharmaceutical Sciences, vol. 15, ed. J. Swarbrick, pp. 451-7. New York and Basel: Marcel Dekker.
12. GODBER, L.M., WALKER, B.D., STEIN, G.E., HAUFTMAN, J.G. & DERKSEN, F.J. (1995). Pharmacokinetics, nephrotoxicosis and in vitro antibacterial activity associated with single versus multiple (three times) daily gentamicin treatments in horses. American Journal of Veterinary Research 56, 613-8.
13. GRAMICCIA, M., GRADONI, L. & ORSINI, S. (1992). Decreased sensitivity to meglumine antimoniate (glucantim) of Leishmania infantum isolated from dogs after several courses of drug treatment. Annals of Tropical Medicine and Parasitology 86, 613-20.
14. GRAMICCIA, M., GRANDONI, L. & ANGELICI, M.C. (1989). Epidemiology of Mediterranean leishmaniasis by Leishmania infantum isoenzyme and kDNA analysis for identification of parasites from man, vectors and reservoirs. In Leishmaniases: the Current Status and New Strategies for Control, NATO-ASI Series, Series A, vol. 163, ed. Hart D.T., pp.21-37. New York: Plenum Press.
15. GRANDONI, L., MAROLI, M., GRAMICCIA, M. & MANCIANTI, F. (1987). Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Medical and Veterinary Entomology 1, 339-42.
16. GROG, M., THOMASON, T.N. & FRANKE, E.D. (1992). Drug resistance in leishmaniasis: its implications in systemic chemotherapy of cutaneous and mucocutaneous disease. American Journal of Tropical Medicine and Hygiene 47, 117-26.
17. HUSTINX, W.N.M. & HOEPELMAN, I.M. (1993). Aminoglycoside dosage regimens. Is once a day enough? Clinical Pharmacokinetics 25, 427-32.
18. JASER, M.A., EL-YAZIGI, A. & CROFT, S.L. (1995). Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis. Pharmaceutical Research 12, 113-6.
19. LAM, F.C. HUNG, C.T. & PERRIER, D.G. (1985). Estimation of variance for harmonic mean half-lives. Journal of Pharmaceutical Sciences 74, 229-31.
20. MARQUARDT, D.W. (1975). An algorithm for least-square estimation of non-linear parameters. Journal of the Society of Industrial and Applied Mathematics 11, 431-41.
21. OLIVA G., CIARAMELLA, P., CORTESE, L. & GRADONI, L. (1995). Valutazione dell'attività dell'aminosidina e dell'antimoniato di N-metilglucamina da soli o in associazione nel trattamento della leishmaniosi del cane. Atti Società Italiana Scienze Veterinarie 49, 767-8.
22. OLIVA, G., CORTESE, L., CIARAMELLA, P. & DE LUNA, R. (1996). Trattamento terapeutico della leishmaniosi del cane. Veterinaria 3, 115-27.
23. PERSECHINO, A., OLIVA, G., CIARAMELLA, P., DE LUNA, R. & CORTESE, L. (1994). Impiego dell'aminosidina nella terapia della leishmaniosi del cane. Rivista di Zootecnia e Veterinaria 22, 11-6.
24. PERSECHINO, A., OLIVA, G., CIARAMELLA, P., DE LUNA, R. & CORTESE, L. (1995). Impiego dell'aminosidina nella terapia della leishmaniosi del cane. Nota I. Rivista di Zootecnia e Veterinaria 23, 37.
25. POLI, A., SOZZI, S., GUIDI, G., BANDINELLI, P. & MANCIANTI, F. (1997). Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis. Veterinary Parasitology 71, 263-71.
26. RIEGELMAN, S. & COLLIER, P. (1980). The application of statistical moment theory to evaluation of in vivo dissolution time and absorption time. Journal of Pharmacokinetics and Biopharmaceutics 8, 509-34.
27. SCOTT, J.A.G., DAVIDSON, R.N., MOODY, A.H., GRANT, H.R., FELMINGHAM, D., SCOTT, G.M.S., OLLIARO, P. & BRYCESON, A.D.M. (1992). Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 617-9.
28. SHAIKH, B., ALLEN, E.H. & GRIDLEY, J.C. (1985). Determination of neomycin in animal tissue using ion pair liquid chromatography with fluorimetric detection. Journal of the Association of Official Analytical Chemists 68, 29-36.
29. TASSI, P., ORMAS, P., MADONNA, M., CARLI, S., BELLOLI, C., DE NATALE, G., CECI, L. & MARCOTRIGIANO, G.O. (1994). Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog. Research in Veterinary Science 56, 144-50.
30. VALLADARES, J.E., ALBERTOLA, J., ESTEBAN, M. & ARBOIX, M. (1996). Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs. The Veterinary Record 138, 181-3.
31. WHO (1990). Control of the Leishmaniasis. Geneve: World Health Organization, Technical Report Series, no 793
32. YAMAOKA, K., NAKAGAWA, T. & UNO, T. (1978). Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equation. Journal of Pharmacokinetia and Biopharmaceutics 6, 165-75.